These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 15522037

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Crystallizing new approaches for antimicrobial drug discovery.
    Schmid MB.
    Biochem Pharmacol; 2006 Mar 30; 71(7):1048-56. PubMed ID: 16458857
    [Abstract] [Full Text] [Related]

  • 43. Use of constraint-based modeling for the prediction and validation of antimicrobial targets.
    Trawick JD, Schilling CH.
    Biochem Pharmacol; 2006 Mar 30; 71(7):1026-35. PubMed ID: 16329998
    [Abstract] [Full Text] [Related]

  • 44. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD.
    J BUON; 2007 Sep 30; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [Abstract] [Full Text] [Related]

  • 45. Overview of issues pertaining to the manufacture, distribution, and use of antimicrobials in animals and other information relevant to animal antimicrobial use data collection in the United States.
    Viola C, DeVincent SJ.
    Prev Vet Med; 2006 Feb 24; 73(2-3):111-31. PubMed ID: 16297998
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. The trials and tribulations of drug development for functional gastrointestinal disorders.
    Chang L.
    Neurogastroenterol Motil; 2008 May 24; 20 Suppl 1():130-8. PubMed ID: 18402650
    [Abstract] [Full Text] [Related]

  • 48. Regulatory opportunities to encourage technology solutions to antibacterial drug resistance.
    Finch R, BSAC Working Party on The Urgent Need: Regenerating Antibacterial Drug Discovery and Development.
    J Antimicrob Chemother; 2011 Sep 24; 66(9):1945-7. PubMed ID: 21700629
    [Abstract] [Full Text] [Related]

  • 49. [Antibiotheraphy in the 21st century, antibacterials for the second decade. Posibilities or realities in the future?].
    García-Sánchez JE, García-Merino E, Martín-del-Rey A, García-Sánchez E.
    Rev Esp Quimioter; 2012 Jun 24; 25(2):100-21. PubMed ID: 22707099
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Antimicrobial stewardship: concepts and strategies in the 21st century.
    Owens RC.
    Diagn Microbiol Infect Dis; 2008 May 24; 61(1):110-28. PubMed ID: 18384997
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. The role of poverty in antimicrobial resistance.
    Planta MB.
    J Am Board Fam Med; 2007 May 24; 20(6):533-9. PubMed ID: 17954860
    [Abstract] [Full Text] [Related]

  • 55. Methuselah's medicine: pharmaceutical innovation and mortality in the United States, 1960-2000.
    Schnittker J, Karandinos G.
    Soc Sci Med; 2010 Apr 24; 70(7):961-8. PubMed ID: 20100632
    [Abstract] [Full Text] [Related]

  • 56. Novel target sites in bacteria for overcoming antibiotic resistance.
    Black MT, Hodgson J.
    Adv Drug Deliv Rev; 2005 Jul 29; 57(10):1528-38. PubMed ID: 15949866
    [Abstract] [Full Text] [Related]

  • 57. Opportunities and challenges in antiparasitic drug discovery.
    Pink R, Hudson A, Mouriès MA, Bendig M.
    Nat Rev Drug Discov; 2005 Sep 29; 4(9):727-40. PubMed ID: 16138106
    [Abstract] [Full Text] [Related]

  • 58. Economics of new oncology drug development.
    DiMasi JA, Grabowski HG.
    J Clin Oncol; 2007 Jan 10; 25(2):209-16. PubMed ID: 17210942
    [Abstract] [Full Text] [Related]

  • 59. [Development of resistances to antibiotic drugs: causes, consequences and importance to the public health system].
    Martínez-Martínez L, Calvo J.
    Enferm Infecc Microbiol Clin; 2010 Nov 10; 28 Suppl 4():4-9. PubMed ID: 21458693
    [Abstract] [Full Text] [Related]

  • 60. Challenges in the discovery and development of new agents for the treatment of obesity.
    Staten MA.
    Clin Pharmacol Ther; 2007 May 10; 81(5):753-5. PubMed ID: 17377527
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.